143 related articles for article (PubMed ID: 11920739)
1. FHIT expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival.
Ramp U; Caliskan E; Ebert T; Karagiannidis C; Willers R; Gabbert HE; Gerharz CD
J Pathol; 2002 Apr; 196(4):430-6. PubMed ID: 11920739
[TBL] [Abstract][Full Text] [Related]
2. Different immunohistochemical patterns of Fhit protein expression in renal neoplasms.
Eyzaguirre EJ; Miettinen M; Norris BA; Gatalica Z
Mod Pathol; 1999 Oct; 12(10):979-83. PubMed ID: 10530564
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of CD95 receptor expression in clear cell renal carcinomas.
Ramp U; Bretschneider U; Ebert T; Karagiannidis C; Willers R; Gabbert HE; Gerharz CD
Hum Pathol; 2003 Feb; 34(2):174-9. PubMed ID: 12612886
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
Yang Q; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Nakamura M; Nakamura Y; Wang X; Mori I; Sakurai T; Kakudo K
Clin Cancer Res; 2001 Dec; 7(12):3869-73. PubMed ID: 11751477
[TBL] [Abstract][Full Text] [Related]
5. Absence or reduction of Fhit expression in most clear cell renal carcinomas.
Hadaczek P; Siprashvili Z; Markiewski M; Domagala W; Druck T; McCue PA; Pekarsky Y; Ohta M; Huebner K; Lubinski J
Cancer Res; 1998 Jul; 58(14):2946-51. PubMed ID: 9679951
[TBL] [Abstract][Full Text] [Related]
6. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
Zhao P; Lu Y; Zhong M; Liu L; Li B
Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
[TBL] [Abstract][Full Text] [Related]
8. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.
Rohr UP; Rehfeld N; Geddert H; Pflugfelder L; Bruns I; Neukirch J; Rohrbeck A; Grote HJ; Steidl U; Fenk R; Opalka B; Gabbert HE; Kronenwett R; Haas R
Clin Cancer Res; 2005 Jan; 11(1):180-5. PubMed ID: 15671544
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of fragile histidine triad expression in prostate carcinoma.
Fouts RL; Sandusky GE; Zhang S; Eckert GJ; Koch MO; Ulbright TM; Eble JN; Cheng L
Cancer; 2003 Mar; 97(6):1447-52. PubMed ID: 12627509
[TBL] [Abstract][Full Text] [Related]
11. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].
Yao CC; Lin CY; Hu MB
Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965
[TBL] [Abstract][Full Text] [Related]
12. Decreased FHIT protein expression correlates with a worse prognosis in patients with diffuse large B-cell lymphoma.
Chen PM; Yang MH; Hsiao LT; Yu IT; Chu CJ; Chao TC; Yen CC; Wang WS; Chiou TJ; Liu JH
Oncol Rep; 2004 Feb; 11(2):349-56. PubMed ID: 14719066
[TBL] [Abstract][Full Text] [Related]
13. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
Werner NS; Siprashvili Z; Fong LY; Marquitan G; Schröder JK; Bardenheuer W; Seeber S; Huebner K; Schütte J; Opalka B
Cancer Res; 2000 Jun; 60(11):2780-5. PubMed ID: 10850413
[TBL] [Abstract][Full Text] [Related]
14. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.
Capuzzi D; Santoro E; Hauck WW; Kovatich AJ; Rosato FE; Baffa R; Huebner K; McCue PA
Cancer; 2000 Jan; 88(1):24-34. PubMed ID: 10618602
[TBL] [Abstract][Full Text] [Related]
15. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
Khurana KK; Truong LD; Verani RR
Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between hMSH2 and FHIT gene expression in non-small cell lung cancer].
Zhu LQ; Diao LM; Chen DJ; Li HG; Liu X; Zou ZY; Li BY; Wang M; Liu MQ
Ai Zheng; 2003 Jun; 22(6):571-4. PubMed ID: 12948402
[TBL] [Abstract][Full Text] [Related]
17. Expression of death-associated protein kinase during tumour progression of human renal cell carcinomas: hypermethylation-independent mechanisms of inactivation.
Wethkamp N; Ramp U; Geddert H; Schulz WA; Florl AR; Suschek CV; Hassan M; Gabbert HE; Mahotka C
Eur J Cancer; 2006 Jan; 42(2):264-74. PubMed ID: 16386893
[TBL] [Abstract][Full Text] [Related]
18. Loss of Fhit expression is a predictor of poor outcome in tongue cancer.
Lee JI; Soria JC; Hassan K; Liu D; Tang X; El-Naggar A; Hong WK; Mao L
Cancer Res; 2001 Feb; 61(3):837-41. PubMed ID: 11221865
[TBL] [Abstract][Full Text] [Related]
19. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]